Table 2

Psychotropic Use by Outcome of Competency Restoration

CSTPISTp
Antipsychotic use through stay
    Formulation.027
        Oral146 (59.8)31 (49.2)
        LAI ± oral74 (30.3)18 (28.6)
    Class< .001
        Typical23 (9.4)4 (6.4)
        Atypical117 (48.0)11 (17.5)
        Both80 (32.8)34 (54.0)
    Formulation × Class< .001
        Typical oral11 (4.5)3 (4.8)
        Atypical oral95 (38.9)9 (14.3)
        Typical and atypical oral40 (16.4)19 (30.2)
        Typical LAI ± oral12 (4.9)1 (1.6)
        Atypical LAI ± oral22 (9.0)2 (3.2)
        Typical and atypical LAI ± oral40 (16.4)15 (23.8)
Number of antipsychotics through stay< .001
    One79 (32.4)6 (9.5)
    Two or more141 (57.8)43 (68.3)
Psychiatric medications upon discharge
    Antipsychotics188 (77.1)45 (71.4).352
    Mood stabilizers47 (19.3)26 (41.3)< .001
    Antidepressants69 (28.3)15 (23.8).529
  • n = 244 deemed competent to stand trial; n = 63 deemed permanently incompetent to stand trial. Data are shown as n (%).

  • CST, competent to stand trial; PIST, permanently incompetent to stand trial; LAI, long-acting injectable.